These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9169946)
41. Development of a dermal matrix from glycerol preserved allogeneic skin. Richters CD; Pirayesh A; Hoeksema H; Kamperdijk EW; Kreis RW; Dutrieux RP; Monstrey S; Hoekstra MJ Cell Tissue Bank; 2008 Dec; 9(4):309-15. PubMed ID: 18491218 [TBL] [Abstract][Full Text] [Related]
42. Treatment of necrotising fasciitis using glycerol-preserved skin allografts for temporary wound coverage. Kim SW; Choi IK; Lee JH; Ahn ST; Rhie JW J Wound Care; 2014 Feb; 23(2 Suppl):S20-2. PubMed ID: 24526170 [TBL] [Abstract][Full Text] [Related]
43. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens. Broström H; Troye-Bomberg M; Perlmann P Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009 [TBL] [Abstract][Full Text] [Related]
44. The use of human deceased donor skin allograft in burn care. Leon-Villapalos J; Eldardiri M; Dziewulski P Cell Tissue Bank; 2010 Feb; 11(1):99-104. PubMed ID: 20077178 [TBL] [Abstract][Full Text] [Related]
45. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Markmann JF; Jacobson JD; Kiumura H; Choti MA; Hickey WF; Fox IJ; Silvers WK; Barker CF; Naji A Transplantation; 1989 Sep; 48(3):478-86. PubMed ID: 2571205 [TBL] [Abstract][Full Text] [Related]
46. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity. Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778 [TBL] [Abstract][Full Text] [Related]
47. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens. Hultman CS; Hunt JP; Yamamoto H; Giannopoulos A; deSerres S; Frelinger JA; Meyer AA J Trauma; 1998 Jul; 45(1):25-33; discussion 33-4. PubMed ID: 9680007 [TBL] [Abstract][Full Text] [Related]
48. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis. Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216 [TBL] [Abstract][Full Text] [Related]
49. Microbiological evaluation of glycerolized cadaveric donor skin. van Baare J; Ligtvoet EE; Middelkoop E Transplantation; 1998 Apr; 65(7):966-70. PubMed ID: 9565102 [TBL] [Abstract][Full Text] [Related]
50. Transplantation of long-term cryopreserved allocutaneous tissue by skin graft or microsurgical anastomosis: experimental studies in the rat. Hirasé Y; Kojima T; Takeishi M; Hwang KH; Tanaka M Plast Reconstr Surg; 1993 Mar; 91(3):492-501. PubMed ID: 7679796 [TBL] [Abstract][Full Text] [Related]
51. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. Benichou G; Takizawa PA; Olson CA; McMillan M; Sercarz EE J Exp Med; 1992 Jan; 175(1):305-8. PubMed ID: 1730925 [TBL] [Abstract][Full Text] [Related]
52. Comparison between cryopreserved and glycerol-preserved allografts in a partial-thickness porcine wound model. Yoon C; Lim K; Lee S; Choi Y; Choi Y; Lee J Cell Tissue Bank; 2016 Mar; 17(1):21-31. PubMed ID: 26150190 [TBL] [Abstract][Full Text] [Related]
53. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells. Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237 [TBL] [Abstract][Full Text] [Related]
54. Role of class II histocompatibility antigens in Staphylococcus aureus protein A-induced activation of human T lymphocytes. Romagnani S; Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Damiani G; Ricci M; Ferrone S Cell Immunol; 1985 Jan; 90(1):52-64. PubMed ID: 3871365 [TBL] [Abstract][Full Text] [Related]
55. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. Williams IR; Perry LL J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920 [TBL] [Abstract][Full Text] [Related]
56. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014 [TBL] [Abstract][Full Text] [Related]
57. Evolving practice of the Helsinki Skin Bank. Lindford AJ; Frey I; Vuola J; Koljonen V Int Wound J; 2010 Aug; 7(4):277-81. PubMed ID: 20492012 [TBL] [Abstract][Full Text] [Related]
58. Antibiotics in the preservation of allograft and xenograft skin. Csönge L; Pellet S; Szenes A; István J Burns; 1995 Mar; 21(2):102-5. PubMed ID: 7766317 [TBL] [Abstract][Full Text] [Related]
59. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680 [TBL] [Abstract][Full Text] [Related]
60. Use of glycerolized human allografts as temporary (and permanent) cover in adults and children. Hussmann J; Russell RC; Kucan JO; Hebebrand D; Bradley T; Steinau HU Burns; 1994; 20 Suppl 1():S61-5; discussion S65-6. PubMed ID: 8198747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]